```json
{
"content": [
{
"type": "paragraph",
"content": "The Disposable Hemodialysis Catheter Kit industry trends over the past 18 months have been reshaped by a wave of consolidation and innovation. In Q1 2024, Baxter International completed its $1.7 bn acquisition of Mitra Industries, folding a next-generation antimicrobial catheter platform into its acute renal portfolio and immediately doubling U.S. kit output at its Opelika plant. Meanwhile, Fresenius Medical Care and Nipro Corporation formed a strategic alliance (signed March 2024) to co-develop low-profile dual-lumen kits with embedded RFID tags that track dwell time; pilot programs in 12 EU centers have already cut CRBSI rates by 32 %."
},
{
"type": "paragraph",
"content": "Product launches have focused on single-use eco-kits: B. Braun launched SustainCath (June 2024) made from 65 % bio-based polymer, while Teleflex gained FDA 510(k) clearance for its Arrow Eco pack with recyclable blister trays. On the regulatory front, the EU MDR extension to December 2025 gave manufacturers breathing room but triggered a scramble for updated clinical data, pushing several mid-tier players to delay launches."
},
{
"type": "paragraph",
content: "Venture funding has pivoted toward home-hemodialysis kits: CatHealth Technologies closed a $41 m Series B (January 2024) to scale a sterile, pre-connected catheter kit tailored for the 28 % YoY growth in U.S. home programs. Expect further M&A as large med-techs seek catheter-kit assets to secure bundled dialysis contracts."
}
]
}
```